Hypofractionated Preoperative Radiation
Showing 1 - 25 of >10,000
Head Neck Cancer Trial in Milwaukee (46 Gy Radiation Therapy, 40 Gy Radiation Therapy, 35 Gy Radiation Therapy)
Not yet recruiting
- Head and Neck Cancer
- 46 Gy Radiation Therapy
- +2 more
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Sep 9, 2022
Pancreatic Cancer Trial in Houston (MRx0518, Hypofractionated Preoperative Radiation)
Active, not recruiting
- Pancreatic Cancer
- MRx0518
- Hypofractionated Preoperative Radiation
-
Houston, TexasMD Anderson Cancer Center
Jul 5, 2022
Recurrent Adult Soft Tissue Sarcoma Trial in Los Angeles (procedure, radiation, other)
Recruiting
- Recurrent Adult Soft Tissue Sarcoma
- Conventional Surgery
- +3 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Mar 2, 2022
Breast Cancer Trial in Houston (Group 1 (preoperative radiation hypofractionated), Group 2 (preoperative radiation
Not yet recruiting
- Breast Cancer
- Group 1 (preoperative radiation hypofractionated)
- Group 2 (preoperative radiation conventionally fractionated)
-
Houston, TexasM D Anderson Cancer Center
Mar 15, 2023
Soft Tissue Sarcoma Trial in Charleston (Hypofractionated Radiation Therapy)
Not yet recruiting
- Soft Tissue Sarcoma
- Hypofractionated Radiation Therapy
-
Charleston, South CarolinaMedical University of South Carolina
Mar 8, 2023
Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical
Not yet recruiting
- Clinical Stage I Esophageal Adenocarcinoma AJCC v8
- +5 more
- Biospecimen Collection
- +9 more
-
Scottsdale, Arizona
- +2 more
Oct 11, 2023
Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IVA
Withdrawn
- Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
- +6 more
- hypofractionated radiation therapy
- +3 more
-
New Brunswick, New Jersey
- +1 more
Sep 27, 2022
Rectal Tumors, Rectal Tumor Malignant Trial in Iowa City (Niraparib, Dostarlimab, Short course radiation)
Recruiting
- Rectal Neoplasms
- Rectal Neoplasm Malignant
- Niraparib
- +2 more
-
Iowa City, IowaHolden Comprehensive Cancer Center at the University of Iowa
Jul 22, 2022
Resectable Soft Tissue Sarcoma, Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IA Soft Tissue Sarcoma
Recruiting
- Resectable Soft Tissue Sarcoma
- +4 more
- Hypofractionated Radiation Therapy
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Brain Metastases, Adult Trial (Hypofractionated Radiosurgery (HSRS), Brain metastases surgical resection)
Not yet recruiting
- Brain Metastases, Adult
- Hypofractionated Radiosurgery (HSRS)
- Brain metastases surgical resection
- (no location specified)
Oct 4, 2022
Cervical Cancer, Endometrial Cancer Trial (Hypofractionated Image guided External Beam Radiation Therapy (EBRT), Cisplatin,
Not yet recruiting
- Cervical Cancer
- Endometrial Cancer
- Hypofractionated Image guided External Beam Radiation Therapy (EBRT)
- +2 more
- (no location specified)
May 11, 2023
Breast Tumors Trial in Beijing (Preoperative MRI-guided tumor-bed boost and postopreative ultra-hypofractionated radiotherapy
Recruiting
- Breast Neoplasms
- Preoperative MRI-guided tumor-bed boost and postopreative ultra-hypofractionated radiotherapy (26 Gy/5.2Gy/5)
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Nov 1, 2022
Soft Tissue Sarcoma Trial in Milwaukee (Hypofractionated Radiation Therapy)
Active, not recruiting
- Soft Tissue Sarcoma
- Hypofractionated Radiation Therapy
-
Milwaukee, WisconsinFroedtert Hospital
Mar 23, 2022
Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Scottsdale, Rochester
Active, not recruiting
- Prostate Adenocarcinoma
- +5 more
- Androgen Suppression
- +3 more
-
Scottsdale, Arizona
- +1 more
Jan 5, 2023
Soft Tissue Sarcoma Trial in France (Patients will receive the hypofractionated radiation therapy (30 Gy in 5 fractions) prior
Not yet recruiting
- Soft Tissue Sarcoma
- Patients will receive the hypofractionated radiation therapy (30 Gy in 5 fractions) prior to surgery.
- Patient will undergo surgery before receive the adjuvant hypofractionated radiation therapy (40 Gy in 15 fractions).
-
Bordeaux, France
- +10 more
Aug 28, 2023
Diffuse Midline Glioma, H3 K27M-Mutant Trial in Rochester (Hypofractionated Radiation Therapy, Quality-of-Life Assessment,
Recruiting
- Diffuse Midline Glioma, H3 K27M-Mutant
- Hypofractionated Radiation Therapy
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 6, 2023
Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7 Trial in Scottsdale, Jacksonville,
Active, not recruiting
- Stage I Breast Cancer AJCC v7
- +6 more
- Hypofractionated Radiation Therapy
- +2 more
-
Scottsdale, Arizona
- +2 more
Jan 3, 2023
Hepatocellular Carcinoma Trial in Lille (Surgery with Neoadjuvant stereotactic body radiation therapy)
Recruiting
- Hepatocellular Carcinoma
- Surgery with Neoadjuvant stereotactic body radiation therapy
-
Lille, FranceHop Claude Huriez Chu Lille
Jul 4, 2022
Soft Tissue Sarcoma, Retroperitoneal Sarcoma, Radiotherapy Side Effect Trial in Beijing (ultra-hypofractionated radiotherapy)
Recruiting
- Soft Tissue Sarcoma
- +4 more
- ultra-hypofractionated radiotherapy
-
Beijing, Beijing, ChinaRadiotherapy Department of Cancer Hospital, Chinese Academy of M
Jan 25, 2022
Resectable Head and Neck Squamous Cell Carcinoma Trial in Milwaukee (42 Gy Radiation Therapy, 39 Gy Radiation Therapy, 32.5 Gy
Suspended
- Resectable Head and Neck Squamous Cell Carcinoma
- 42 Gy Radiation Therapy
- +2 more
-
Milwaukee, WisconsinFroedtert & the Medical College of Wisconsin
Jan 13, 2023
Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
Not yet recruiting
- Breast Carcinoma
- Invasive Breast Carcinoma
- Biopsy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 28, 2022
Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Moderately hypofractionated conformal radiation combined With S-1)
Completed
- Esophageal Squamous Cell Carcinoma
- Moderately hypofractionated conformal radiation combined With S-1
-
Guangzhou, Guangdong, ChinaHui Liu
Oct 25, 2022
Ductal Breast Carcinoma in Situ, Invasive Breast Cancer, Early-stage Breast Cancer Trial in Mérida (Hypofractionated
Recruiting
- Ductal Breast Carcinoma in Situ
- +6 more
- Hypofractionated radiotherapy
-
Mérida, Yucatán, MexicoUnidad Medica de Alta Especialidad
Nov 7, 2022
Soft Tissue Sarcoma Trial in Palo Alto (External Beam Radiotherapy)
Recruiting
- Soft Tissue Sarcoma
- External Beam Radiotherapy
-
Palo Alto, CaliforniaStanford University
Oct 11, 2023
Non Small Cell Lung Cancer Trial in Sweden (Standard systemic therapy + radiotherapy, Standard systemic therapy)
Not yet recruiting
- Non Small Cell Lung Cancer
- Standard systemic therapy + radiotherapy
- Standard systemic therapy
-
Gothenburg, Sweden
- +5 more
Nov 17, 2023